Virtual Support, Real Impact: Effectiveness of Tele-nursing in Alleviating Chemotherapy Symptoms Among Cancer Patients
1 other identifier
interventional
74
1 country
1
Brief Summary
This quasi-experimental study evaluated a tele-nursing educational program's impact on improving the quality of life and managing chemotherapy-related symptoms in 74 adult cancer patients at Mansoura University Hospital in Egypt. Delivered via Telegram, the program involved weekly educational sessions, aiming to enhance symptom management and quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable cancer
Started Jan 2024
Shorter than P25 for not_applicable cancer
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
January 1, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 30, 2024
CompletedStudy Completion
Last participant's last visit for all outcomes
August 30, 2024
CompletedFirst Submitted
Initial submission to the registry
November 20, 2024
CompletedFirst Posted
Study publicly available on registry
November 25, 2024
CompletedNovember 25, 2024
November 1, 2024
4 months
November 20, 2024
November 22, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
cancer-related and treatment-related symptoms
The M.D. Anderson Symptom Inventory Arabic Version (MDASI-A), adapted from Nejmi et al. (2010), was utilized to assess the severity of cancer-related and treatment-related symptoms in a manner accessible to Arabic-speaking patients. Designed in straightforward Arabic, the tool evaluates both the intensity of 13 core symptoms commonly experienced by cancer patients and their interference with daily functioning. This makes the MDASI-A comprehensive while remaining brief enough to avoid imposing a burden on respondents. The MDASI-A employs a 0-2 numerical scale (Never = 0, Sometimes = 1, Always = 2), ensuring its usability even among less-educated individuals. It is also adaptable for telephone, computer, and other electronic methods of administration. Scores were converted to percentages to classify symptom intensity into three categories: low (\<50%), average (50% to \<75%), and high (≥75%) based on the method proposed by Daisuke and Makoto (2022).
3 months
Secondary Outcomes (1)
Quality of life for Cancer Patients
3 months
Study Arms (1)
Enrolled participants
EXPERIMENTALThe intervention administered in this study was a tele-nursing educational program aimed at improving cancer patients' management of chemotherapy-related symptoms and enhancing their quality of life. The program was delivered via a Telegram group, which provided a platform for regular interaction between the patients and nursing staff. The educational content was designed to address common chemotherapy-related symptoms, such as nausea, fatigue, pain, and loss of appetite, and to provide guidance on managing these symptoms effectively.
Interventions
The intervention administered in this study was a tele-nursing educational program aimed at improving cancer patients' management of chemotherapy-related symptoms and enhancing their quality of life. The program was delivered via a Telegram group, which provided a platform for regular interaction between the patients and nursing staff. The educational content was designed to address common chemotherapy-related symptoms, such as nausea, fatigue, pain, and loss of appetite, and to provide guidance on managing these symptoms effectively.
Eligibility Criteria
You may qualify if:
- Diagnosed with cancer and receiving treatment at an outpatient chemotherapy center
- Age from 20 less than 60 years.
- Accept to participate in the study.
- Had smart phones linked with internet
- Educated and able to use Zoom and Telegram applications
You may not qualify if:
- Having active, serious physical disease
- Patients with mental disease.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Mansura university
Al Mansurah, Dakhalia, 35516, Egypt
MeSH Terms
Conditions
Study Officials
- PRINCIPAL INVESTIGATOR
Alaa El Din M Abd Elaleem, PhD
Faculty of Nursing
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Purpose
- SUPPORTIVE CARE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Lecturer of Psychiatric and mental health Nursing
Study Record Dates
First Submitted
November 20, 2024
First Posted
November 25, 2024
Study Start
January 1, 2024
Primary Completion
April 30, 2024
Study Completion
August 30, 2024
Last Updated
November 25, 2024
Record last verified: 2024-11
Data Sharing
- IPD Sharing
- Will not share